flutamide has been researched along with Carcinoma, Transitional Cell in 1 studies
Flutamide: An antiandrogen with about the same potency as cyproterone in rodent and canine species.
Carcinoma, Transitional Cell: A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, F | 1 |
| Langenstroer, P | 1 |
| Zhang, G | 1 |
| Iwamoto, Y | 1 |
| See, W | 1 |
1 other study available for flutamide and Carcinoma, Transitional Cell
| Article | Year |
|---|---|
Androgen dependent regulation of bacillus Calmette-Guerin induced interleukin-6 expression in human transitional carcinoma cell lines.
Topics: Androgen Antagonists; Anilides; Autocrine Communication; BCG Vaccine; Carcinoma, Transitional Cell; | 2003 |